aBStraCt Introduction: Candidemia is a bloodstream infection produced by Candida genus yeasts. Objectives: The purpose of this study was to characterize the epidemiology and the fluconazole susceptibility in Candida species isolated from patients at a regional hospital in Passo Fundo, RS. Methods: Records from the laboratory were used to identify patients with positive blood cultures for Candida between 2010 and 2011. The in vitro activity of fluconazole was determined using the disk diffusion method. Results: Were analyzed 24 positive blood cultures for Candida and found a 54.16% mortality rate. C. albicans was the most prevalent species, followed by C. parapsilosis and C. krusei. For susceptibility to fluconazole, C. albicans, C. parapsilosis and C. tropicalis showed 100% sensitivity. However, C. krusei was 100% resistant; and C. glabrata, 50% resistant. Conclusion: The high mortality and fluconazole resistance rates emphasize the importance of the diagnosis of candidemia in a hospital environment.
introDuCtion
Bloodstream infections by Candida genus yeasts are the fourth cause of septicemia in US hospitals (1) . The most frequently isolated species in hospitals is the Candida albicans (2) (3) (4) ; however, non-albicans Candida species may be responsible for more than half of candidemia cases (5) . And as the number of reports about the antifungal-resistant Candida species has been increasing (6) (7) (8) (9) , the early establishment of an adequate treatment of candidemia is associated with a favorable prognosis (10) .
In the latest decades, the number of publications that document improved attention to health regarding candidemia in different populations has increased (11) . Due to variations in the geographical distribution of Candida species able to produce septicemia in different regions of the planet, local epidemiological data continue to be very important (12) . Knowing the resistance profiles of Candida species to fluconazole plays an important role in the management of candidemia, considering that this antifungal drug is used for prophylaxis in hospitalized patients (13) .
oBjECtivES
The current work was aimed at identifying species of the Candida genus isolated from blood cultures of hospitalized patients at Hospital São Vicente de Paulo (HSVP), in the city of Passo Fundo (RS), Brazil, and determining their antifungal susceptibility profile to fluconazole. 2010 and December 2011. Participants' data were transcribed from clinical information of candidemia patients provided by the microbiology sector of the HSVP clinical laboratory.
Inclusion criteria
All blood samples sent to the HSVP clinical laboratory for culture and Gram staining were used. They were collected from inpatients whose results were positive for Candida genus yeasts.
Exclusion criteria
Candida samples from the same patient that presented growth in different days were excluded, that is, just one sample from each patient was included.
Sample processing
Positive blood cultures were detected at an automated system, by a conventional method.
Yeast identification
Yeast identification was performed by Gram staining, macromorphology and micromorphology of the colonies, germ tube formation, growth characteristics of Candida on a chromogenic medium, auxanogram and zimogram methods (14, 15) . Samples were processed at the HSVP clinical laboratory and at the mycology laboratory of Universidade Regional Integrada (URI) Erechim.
Fluconazole susceptibility test
The susceptibility tests were carried out by the M44-A2 (16) method. Fluconazole 25 mcg disks, produced by Centro de Controle e Produtos para Diagnósticos Ltda. (CECON), were used in the research. The standard strain of Candida albicans (ATCC 90028) was used as the control.
Ethical aspects
The project under number 085/PGH/2011 was approved by the research ethics committee of URI Erechim and HSVP.
rESuLtS
From December 2010 to December 2011, 24 episodes of candidemia occurred at HSVP. Concerning patient distribution according to age group, 12 were adults (62 ± 14.6 years), and 12 were children (7 ± 2.7 years) -among these, seven were newborn. Still among the children, the female:male ratio was 4:8; among the adults, this value was 3:9. The death percentage was 54.17% (13/24), of which seven were children, and six were adults. All participants were on antibiotic drugs, and two used fluconazole. Just a third of the patients were inhabitants of Passo Fundo; the remaining patients lived in other towns of Rio Grande do Sul. Table 1 shows the distribution of Candida species in the studied population. Candida albicans was the prevalent species, present in 41.67% of the cases, followed by C. parapsilosis (16.67%), C. krusei (12.5%), C. tropicalis (8.33%) and C. glabrata (8.33%). Non-albicans Candida species were responsible for 58.33% of candidemia cases. The occurrence of C. parapsilosis was observed only in the child population; C. krusei, only in adults. The identification of three non-albicans Candida species was not made, due to the absence of growth after replica plating.
The fluconazole susceptibility profile of Candida species is described in Table 2 . C. albicans, C. parapsilosis, and C. tropicalis presented 100% sensitivity to fluconazole. In relation to C. glabrata isolates, 50% presented fluconazole resistance; and 50%, intermediate profile. All the C. krusei isolates presented resistance to fluconazole.
Candida species distribution and fluconazole susceptibility of blood isolates at a regional hospital in Passo Fundo, RS, Brazil 
DiSCuSSion
Epidemiological surveys conducted in different countries pointed C. albicans as the species responsible for most candidemia episodes (17, 18) . In a recent multicentric study carried out in the USA, the most prevalent species were C. albicans (50.7%), followed by C. parapsilosis (17.4%), C. glabrata (16.7%), and C. tropicalis (10.2%). Concerning the susceptibility profile to fluconazole, 0.8% of the C. albicans isolates, 100% of the C. glabrata isolates, 2.9% of the C. parapsilosis isolates and 4.9% of the C. tropicalis isolates presented resistance (17) . C. glabrata is also described as the second most common Candida species to produce septicemia (19) .
The increased incidence of non-albicans Candida species as causing agents of candidemia has been reported. Among these species, C. parapsilosis was the most frequent, a result similar to that described in other investigations conducted in Brazil (2, 4, 20, 21) ; however, in another survey, C. tropicalis was the most frequent non-albicans species (3) .
In this study, regarding the non-albicans Candida species, C. parapsilosis was found just in children. The prevalence of this species in the pediatric population is reported in other analyses (21, 22) . Mortality rates higher than 50% were found in other studies (2, 3, 20, 21) , besides having been described in surveys in other countries. A retrospective study conducted in Africa between 1990 and 2007 identified 73% mortality in 2.066 candidemia patients (23) .
The isolation percentage of C. krusei in different anatomical sites ranged from 0.3% to 7.6% (24) . This species is intrinsically resistant to fluconazole (25) , as well as C. glabrata (26) . Echinocandin has shown to be the most active antifungal drug (24) . C. tropicalis resistance has also become a matter of concern, so that in a survey conducted in the state of Ceará, 5.9% of the C. tropicalis isolates were resistant to fluconazole and itraconazole (9) .
The results of this analysis emphasize the importance of surveillance programs to assess the distribution of antifungal resistance trends in Candida species. The differences in the resistance profiles associated to different species stress the need of local epidemiological data capable of guiding treatment at a hospital level.
ConCLuSion
C. albicans was the most common species found in candidemia in patients hospitalized at HSVP, followed by C. parapsilosis, C. krusei, C. tropicalis and C. glabrata. This group of pathogens is associated with mortality indices higher than 50% in septicemia. The occurrence of C. parapsilosis was observed only in children; while C. krusei, only in adults. C. glabrata and C. krusei may present problems in relation to their profile of resistance to fluconazole. 
